Dinuclear platinum(II)-anthracene complexes as lysosomal-localized photodynamic anticancer agents
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Metal complexes synthesis and properties · Porphyrin and Phthalocyanine Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
2. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
3. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization10.1021/cr900300p ↗
4. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
5. Activatable photosensitizers: from fundamental principles to advanced designs
6. Subcellular organelle targeted tumor phototherapy10.1016/j.ccr.2025.216635 ↗
7. NIR-II AIEgens for infectious diseases phototheranostics10.1002/anie.202414259 ↗
8. Manipulating the dynamics of dark excited states in organic materials for phototheranostics10.1021/acs.accounts.0c00688 ↗
9. Oxygen self-sufficient photodynamic therapy10.1016/j.ccr.2020.213714 ↗
10. Smart molecular designs and applications of activatable organic photosensitizers10.1038/s41570-024-00662-7 ↗
11. A type I/II photosensitizer with lysosome-targeting capabilities induces immunogenic cell death in cancer cells to enhance tumor immunotherapy10.1021/acsnano.5c14676 ↗
12. PDT and antitumor immunity: the beginnings of the story10.1007/s43630-024-00627-1 ↗
13. Tumor-microenvironment-activated reactive oxygen species amplifier for enzymatic Cascade cancer starvation/chemodynamic/immunotherapy
14. Photodynamic therapy and anti-tumour immunity10.1038/nrc1894 ↗
15. Recent progresses in phototherapy-synergized cancer immunotherapy
16. Immunogenic cell death inducing metal complexes for cancer therapy
17. Augmenting cancer therapy with a supramolecular immunogenic cell death inducer: a lysosome-targeted NIR-light-activated ruthenium(II) metallacycle10.1021/jacs.3c13224 ↗
18. Molecular architectures of multi-anthracene assemblies10.1039/C3CS60315F ↗
19. Anthracene-based endoperoxides as self-sensitized singlet oxygen carriers for hypoxic-tumor photodynamic therapy10.1002/adhm.202403009 ↗
20. Dinuclear anthracene-containing alkynylplatinum(II) terpyridine complexes with photo-modulated self-assembly behaviors10.1039/D0QM00972E ↗
21. An anthracene functionalized BODIPY derivative with singlet oxygen storage ability for photothermal and continuous photodynamic synergistic therapy10.1039/C9TB00180H ↗
22. Near-infrared light triggered photothermal and photodynamic therapy with an oxygen-shuttle endoperoxide of anthracene against tumor hypoxia10.1039/C8PY00289D ↗
23. Anthracene-bisphosphonate based novel fluorescent organic nanoparticles explored as apoptosis inducers of cancer cells10.1039/c3cc44989k ↗
24. Fluorescent mixed ligand copper(II) complexes of anthracene-appended schiff bases: studies on DNA binding, nuclease activity and cytotoxicity10.1039/C5DT00899A ↗
25. A discrete organoplatinum(II) metallacage as a multimodality theranostic platform for cancer photochemotherapy10.1038/s41467-018-06574-7 ↗
26. A supramolecular photosensitizer derived from an Arene-Ru(II) complex self-assembly for NIR activated photodynamic and photothermal therapy10.1038/s41467-022-30721-w ↗
27. A Platinum(II)-based photosensitive tripod as an effective photodynamic anticancer agent through DNA damage10.1002/chem.201703598 ↗
28. Nucleus-localized platinum(II)-triphenylamine complexes as potent photodynamic anticancer agents10.1039/C9QI00738E ↗
29. Weber · Eur J Inorg Chem · 2005 · 2005 · 475510.1002/ejic.200500663 ↗
30. Multiple-color platinum complex with super-large stokes shift for super-resolution imaging of autolysosome escape10.1002/anie.202007878 ↗
31. Determination of the lifetime of singlet oxygen in water-d2 using 9,10-anthracenedipropionic acid, a water-soluble probe10.1021/ja00537a030 ↗
32. Photooxidation of tryptophan: O2(1Δg) versus electron-transfer pathway10.1111/j.1751-1097.1997.tb01883.x ↗
33. A NIR-light-activated and lysosomal-targeted Pt(II) metallacycle for highly potent evoking of immunogenic cell death that potentiates cancer immunotherapy of deep-seated tumors10.1002/anie.202483761 ↗
34. A new approach to sensitize antitumor monofunctional platinum(II) complexes via short time photo-irradiation10.1021/acs.inorgchem.6b02148 ↗
35. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy10.1039/C6CS00271D ↗
36. CO/light dual-activatable Ru(II)-conjugated oligomer agent for lysosome-targeted multimodal cancer therapeutics10.1039/D1SC01317C ↗
37. Superoxide radical photogenerator with amplification effect: surmounting the achilles' heels of photodynamic oncotherapy10.1021/jacs.8b13141 ↗
38. Cyclometalated iridium(III) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents10.1039/C5SC01955A ↗
39. Flow cytometry of apoptotic cell death10.1016/S0022-1759(00)00233-7 ↗
40. Dual-organelle targeted photosensitizer with AIE characteristics for triple-negative breast cancer photodynamic therapy via apoptosis and immunogenic cell death
41. An albumin-photosensitizer supramolecular assembly with Type I ROS-induced multifaceted tumor cell deaths for photodynamic immunotherapy
42. The distinct roles of ROS in tumor immunity: from mechanisms to immunotherapeutic applications10.1186/s13045-026-01780-z ↗
43. Induction of immunogenic cell death by novel platinum-based anticancer agents10.1016/j.phrs.2022.106556 ↗